ELANE and cor pulmonale: Using a combination of computationalprediction and in vitro IC50 assays, we demonstrate thepolypharmacological potential of a scaffold that has already led toinhibitors of the human neutrophil elastase, some of which are currentlyin clinical trials targeting cardiopulmonary disease.